Velsera
Founded 2023 · 427 employees on LinkedIn · 4 known investors
Find your way into Velsera
1,365 people in our graph share verified history with the Velsera team — schools, employers, funds. One of them is your warm intro.
Krishna Yeshwantunlockedknows Becky Zimmerman · together at Partners HealthCare Center for Personalized Genetic Medicine (overlapped)
×5knows the team · via McKinsey & Company
knows the team · via Tufts University School of Medicine
×3knows the team · via Children's Hospital Boston
knows the team · via Linköping University
knows the team · via University of Arkansas
Velsera provides integrated software and expert services that turn complex biomedical and genomic data into usable insights for precision medicine, drug discovery, diagnostics development, and genetic testing. It serves organizations in the life sciences and healthcare sectors working on discovery, diagnostics, and regulatory navigation.
Founders & leadership
JC
Jamie CoffininChief Executive OfficerJamie Coffin is Chief Executive Officer of Velsera, a provider of biomedical and genomic data analytics software and services for precision medicine and drug discovery. With over 20 years in healthcare and life sciences, Coffin has held leadership roles in strategy and team management across biomanufacturing, genomics, and informatics domains.
KS
Kareem SaadinPresident and Chief Business Officer
PG
Pavel GongorainChief Strategy and Product OfficerPavel Gongora is Chief Strategy and Product Officer at Velsera, a bioinformatics software and services company focused on precision medicine and drug discovery. He has approximately 20 years of experience in life sciences and healthcare, including prior work as an Associate Partner at McKinsey, and holds a background in medicine.
MK
Mike KlingChief Technology Officer
LC
Lou ClarkeinChief People OfficerLou Clarke is Chief People Officer at Velsera, having previously led HR and organizational transformation initiatives across technology, healthcare, and professional services organizations spanning EMEA, APAC, and the Americas. Clarke holds a CIPD Level 7 qualification in HR Management.
BZ
Becky ZimmermaninSVP Clinical Product and Chief Clinical OfficerShe brings expertise in clinical molecular genetics, genetic diagnostic testing, newborn screening, and prenatal genetics, among other specialties in genetics-based diagnostics.
Investors · 4
In the news
Frequently asked questions
- What does Velsera do?
- Velsera provides integrated software and expert services that turn complex biomedical and genomic data into usable insights for precision medicine, drug discovery, diagnostics development, and genetic testing. It serves organizations in the life sciences and healthcare sectors working on discovery, diagnostics, and regulatory navigation.
- Who are Velsera's investors?
- Velsera's investors include Health Catalyst Capital, OrbiMed, SJF Ventures, Summa Equity.